Status:
COMPLETED
Thoracoscopic Versus Endocardial Ablation in Patient With Paroxysmal AF After Failed Initial Endocardial Ablation
Lead Sponsor:
Meshalkin Research Institute of Pathology of Circulation
Conditions:
Paroxysmal Atrial Fibrillation
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
The investigators aimed to compare two approaches thoracoscopic epicardial ablation and endocardial catheter ablation after failed initial catheter ablation in patients with paroxysmal atrial fibrilla...
Eligibility Criteria
Inclusion
- failed initial catheter ablation
- paroxysmal atrial fibrillation
Exclusion
- chronic lung disease
- body mass index \>35
- longstanding atrial fibrillation 1 year
- previous stroke or transient ischemic attack
- left atrial thrombus
- left atrial size \>65 mm
- left ventricular ejection fraction \<35%
Key Trial Info
Start Date :
May 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01794416
Start Date
May 1 2011
End Date
March 1 2013
Last Update
March 26 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
State Research Institute of Circulation Pathology
Novosibirsk, Russia, 630055